Self-blame and peer victimization in middle school: an attributional analysis |
| |
Authors: | S Graham J Juvonen |
| |
Affiliation: | Thrombosis Research Unit, Foothills Hospital, Alberta, Canada. |
| |
Abstract: | Intravenous heparin followed by warfarin has been the classical anticoagulant therapy of acute venous thromboembolism for the past 30 years. In recent years a number of low-molecular-weight heparins have become available for clinical trials. These agents have a number of advantages over unfractionated heparin and are now being used internationally for the prevention and treatment of venous thromboembolism. Low-molecular-weight heparin will undoubtedly replace intravenous unfractionated heparin not only in the treatment of venous thromboembolism but in other conditions where heparin therapy is indicated. Whether or not the low-molecular-weight heparins can decrease or eliminate some of the complications of unfractionated heparin will depend on the outcome of future clinical trials. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|